Invenomic Capital Management’s Reinsurance Group of America RGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-136,263
Closed -$16M 183
2022
Q2
$16M Buy
136,263
+10,362
+8% +$1.2M 1.13% 23
2022
Q1
$11.3M Buy
125,901
+33,990
+37% +$3.76M 1.2% 22
2021
Q4
$10.1M Buy
91,911
+22,431
+32% +$2.49M 2.15% 6
2021
Q3
$7.73M Buy
69,480
+24,182
+53% +$2.75M 2.51% 7
2021
Q2
$5.16M Buy
45,298
+15,245
+51% +$1.92M 1.24% 13
2021
Q1
$3.79M Buy
30,053
+7,515
+33% +$893K 0.84% 20
2020
Q4
$2.61M Buy
+22,538
New +$2.52M 0.67% 27

Other funds holding RGA

Invenomic Capital Management's RGA Position: Q3 2022 in Review

Invenomic Capital Management sold out of Reinsurance Group of America (RGA) in Q3 2022, closing a stake of 136,263 shares — an estimated $16M sold.

Invenomic Capital Management first reported a position in RGA in Q4 2020 and held it in 7 quarters. The position peaked at $16M in Q2 2022. 406 funds tracked by Wall St. Rank hold RGA as of Q3 2022.

  • Invenomic Capital Management reported no remaining Reinsurance Group of America position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 136,263 Reinsurance Group of America shares in Q3 2022, an estimated $16M.
  • Invenomic Capital Management first reported a position in Reinsurance Group of America in Q4 2020 and held it in 7 quarters.
  • Invenomic Capital Management's Reinsurance Group of America position peaked at $16M in Q2 2022.
  • 406 funds tracked by Wall St. Rank held Reinsurance Group of America as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.